
Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical Company
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve …
Vanda - Wikipedia
Vanda, abbreviated in the horticultural trade as V.,[3] is a genus in the orchid family, Orchidaceae. There are 90 species, [2] and the genus is commonly cultivated for the marketplace.
Vanda Pharmaceuticals Inc. (VNDA) - Yahoo Finance
Find the latest Vanda Pharmaceuticals Inc. (VNDA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Vanda Pharmaceuticals (VNDA) Stock Price, News & Analysis
3 days ago · Vanda Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for central nervous system …
VNDA: Vanda Pharmaceuticals Inc Latest Stock Price ... - Stocktwits
Get real-time Vanda Pharmaceuticals Inc (VNDA) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time …
Vanda Pharmaceuticals (VNDA) Stock Price & Overview
Jan 8, 2026 · A detailed overview of Vanda Pharmaceuticals Inc. (VNDA) stock, including real-time price, chart, key statistics, news, and more.
VNDA Stock Price | Vanda Pharmaceuticals Inc. Stock Quote …
3 days ago · Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag …
Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter …
Jan 8, 2026 · Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and …
Vanda Pharmaceuticals Inc. (VNDA) Latest Stock News | Seeking …
Jan 7, 2026 · Get the latest news and real-time alerts from Vanda Pharmaceuticals Inc. (VNDA) stock at Seeking Alpha.
FDA Approves Vanda Pharma Motion Sickness Drug, Fuels Upside
Jan 6, 2026 · Analysts raise price targets for Vanda Pharmaceuticals after FDA approved a motion sickness drug, citing growth potential.